Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04507139 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 31, 2024 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv10
  2. Primary and study completion dates: Jun 2023 to Jun 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 3 of 3 sites
    v9
  3. Primary and study completion dates: Jan 2023 to Jun 2023
    • Eligibility criteria expanded, about 14 words
    • Study description expanded, about 11 words
    • Site contacts updated at 2 of 3 sites
    v8
  4. Primary and study completion dates: Jan 2022 to Jan 2023v7
  5. Site contacts updated at 1 of 3 sitesv6
Show 4 earlier versionsHide 4 earlier versions
  1. Site details revised at 1 of 3 sitesv5
  2. Start date changed from estimate of Sep 15, 2020 to Sep 10, 2020
    • Site details revised at 1 of 3 sites
    v4
  3. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 1, 2020 to Sep 15, 2020
    • Site details revised at 3 of 3 sites
    v3
  4. Start date: Aug 1, 2020 to Sep 1, 2020v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Directly examine whether early (6-month) imaging with DaTscan and \[¹⁸F\] AV-133 will provide an early signal of disease progression in recently diagnosed untreated PD patients.
Trial Details
NCT Number NCT04507139
Lead Sponsor Michael J. Fox Foundation for Parkinson's Research
Conditions
(from sponsor)		 Parkinson Disease
Related terms Anosmia, Neurodegenerative Diseases, Parkinson Disease
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov